GRAND RAPIDS, Mich., Nov. 20, 2023 – Corewell Health™ was named to professional services and research firm Seramount’s 2023 Inclusion Index. The recognition measures three key areas of an organization: best practices in the recruitment, retention and advancement of people from historically marginalized groups—women, racial/ethnic groups, people with disabilities and LGBTQIA+ people; inclusive company culture; and demographic diversity. Corewell Health was among the 38 organizations recognized as a Leading Inclusion Index Company. This is the second year the organization joins the ranking on the Inclusion Index and Corewell Health’s first year being additionally recognized as a Leading Inclusion Index Company.
ROYAL OAK, Mich., Nov. 14, 2023 – Beaumont Children’s is preparing to light the night for its littlest patients with its beloved holiday tradition, "Moonbeams for Sweet Dreams," Dec. 8-23 at Beaumont Hospital Royal Oak, a part of Corewell Health.
Grand Rapids, Mich., November 6, 2023 – Corewell HealthTM hospitals in Big Rapids, Greenville, Ludington and Zeeland earned an “A” Hospital Safety Grade for fall 2023 from The Leapfrog Group, a national nonprofit watchdog that sets standards for excellence in patient care.
St. Joseph and Niles, Mich., November 6, 2023 – Corewell HealthTM Lakeland Hospitals - St. Joseph Hospital and Corewell Health Lakeland Hospitals - Niles Hospital earned an “A” Hospital Safety Grade for fall 2023 from The Leapfrog Group, a national nonprofit watchdog that sets standards for excellence in patient care.
Grosse Pointe, Mich., November 6, 2023 – Beaumont Hospital, Grosse Pointe, part of Corewell HealthTM, earned an “A” Hospital Safety Grade for fall 2023 from The Leapfrog Group, a national nonprofit watchdog that sets standards for excellence in patient care.
Southfield, Mich., Oct. 18, 2023 – A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.
To date, researchers have struggled to determine any risk factors that could shed light on who might experience these types of side effects ahead of time. But now, a simple MRI scan and a new metric to determine urethra length could change that.
Alzheimer’s disease is the fourth leading cause of death among older Black Americans, a trend that is expected to increase exponentially during the next five to 10 years.
To address the growing disparity and identify multi-level risk factors impacting the higher prevalence of Alzheimer’s disease among middle-aged and older Black adults, Corewell Health neuroscientist and metabolomicist Stewart Graham, Ph.D., an associate professor at Oakland University William Beaumont School of Medicine, in collaboration with Travonia Brown-Hughes, Ph.D., associate professor, Hampton University, and Johns Hopkins Resource Center Minority Aging Research scientist and Roland J. Thorpe, Ph.D., social epidemiologist with Johns Hopkins Bloomberg School of Public Health and director of the Johns Hopkins Alzheimer’s Disease Resource Center for Minority Aging, are spearheading a first-of-its-kind, five-year, $4.8 million research project funded by the National Institutes of Health.
Grand Rapids, Mich., Oct. 3, 2023 – Corewell Health™ has earned high marks in the 2023 College of Healthcare Information Management Executives (CHIME) Digital Health Most Wired survey, a comprehensive “digital health check-up” for health care organizations.
This annual survey acknowledges health care organizations that have adopted and deployed information technology to improve patient safety and health outcomes across the health care industry.
GRAND RAPIDS, Mich., Oct. 2, 2023 – Corewell Health™ has become the first and only health system in Michigan to implant a device intended to improve upper body mobility in patients who have experienced a debilitating stroke.
In clinical trials, the Vivistim Paired VNS System, coupled with intensive rehabilitation therapy, has resulted in improved hand and arm function for stroke survivors.
The FDA-approved device, which was surgically implanted by surgeons at Corewell Health Butterworth Hospital in Grand Rapids, delivers vagus nerve stimulation (VNS) during rehabilitation therapy. The pairing of rehabilitation exercise with VNS creates or strengthens nerve connections in healthy areas of the brain, which increases the effectiveness of the therapy and has been shown to improve upper limb function.
Children’s Miracle Network Hospitals (CMNH) announced financial support for programs at Corewell Health’s Beaumont Children’s. More than $2 million dollars in grants have been issued to enhance pediatric programs at Corewell Health’s Beaumont Children’s locations for fall, 2023. More than 60 programs received funding.
Need a logo? Contact brandhelpdesk@corewellhealth.org for assistance.
High Resolution Photos: